Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Revolution Ascend

GE Revolution Ascend

Enovacom EPC

Enovacom EPC

COVID-19

Concordia collaboration for vaccine making progress

July 29, 2020


Gilles Peslherbe MONTREAL – Researchers at Concordia University are making good progress on development of a COVID-19 vaccine and they’re not doing it at a medical lab, but rather, from the comfort of home.

The team is using state-of-the-art computer simulations and AI to model potential vaccines that can be tested quickly. Applying reverse vaccinology – a scientific method that uses bioinformatics and genome sequencing to break down the virus’s structural information – they’re able to come up with different options for a cost-effective, universal vaccine.

“Because our research enables us to deconstruct the virus using genetic modeling, we’re able to develop a vaccine that will have a long-lasting immune response independent of one’s age, gender or background,” said Gilles Peslherbe (pictured), a Concordia University professor and director of the university’s Centre for Research in Molecular Modeling (CERMM), who is overseeing the Canadian side of the project.

Working with Peslherbe are two researchers who hail from India but come from Henan University of Technology in China. They arrived in Montreal in late December as part of the Mitacs Globalink program – a 24-week internship that has international students and junior scholars working alongside local researchers to foster global research links – and were expected to return to China in April. With the onset of COVID-19 and shelter-in-place orders, however, Mitacs arranged for their Canadian stay to be extended and their work to pivot from lung and cervical cancer research to developing a solution to combat the coronavirus.

The interns, Gurudeeban Selvaraj and Satyavani Kaliamurthi, have regular virtual meetings with Peslherbe, collaborating on the project with international partners at Henan University of Technology and Shanghai Jiao Tong University in China, and Queen Elizabeth Hospital in Hong Kong.

With the Canadian group in the process of optimizing its top vaccine solution through computational research, the partners in China are gearing up for animal clinical trials of the vaccine at their labs later this summer. Peslherbe said the vaccine could be available in early 2021 if everything goes according to plan.

“We wouldn’t have been able to coordinate this research without the collaboration of Mitacs and our international partners,” Peslherbe emphasized. “We have been able to progress so quickly because the interns and partners bring unique expertise that has enabled our research to propel forward.”

Kaliamurthi has a background in cervical cancer research, and because of the similar nature of her previous vaccine research for Cervix Papilloma, an infection that can change cervix cells to pre-cancerous cells, she was able to easily adapt to a COVID-19 solution. Similarly, Selvaraj’s previous work on a new drug design for lung cancer and respiratory conditions helped accelerate his COVID-19 research.

About Mitacs
Mitacs is a not-for-profit organization that fosters growth and innovation in Canada by solving business challenges with research solutions from academic institutions. For information about Mitacs and its programs, see mitacs.ca/newsroom.

PreviousNext

CHT print [900×150]

CHT print [900x150]

News and Trends

  • NS improves care by deploying Command Centres
  • Panel identifies threats from faxes, snooping, cyber-attacks
  • Bringing portable X-ray imaging to Canada’s remote communities
  • In Ontario, real steps are being taken to reach EHR interoperability
  • Care-givers need improved technology to reduce stress in the LTC sector
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Softworks

Softworks

Nihi Spring 2023

Nihi Spring 2023

Advertise with us

Advertise with us

Sectra [Feb]

Sectra [Feb]

Change Healthcare [2]

Change Healthcare [2]

Infoway [March2023]

Infoway [March2023]

Zebra [Mar2023]

Zebra [Mar2023]

RealTime

RealTime

CHT print [900×150]

CHT print [900x150]

Advertise with us

Advertise with us

Sectra [Feb]

Sectra [Feb]

Change Healthcare [2]

Change Healthcare [2]

Infoway [March2023]

Infoway [March2023]

Zebra [Mar2023]

Zebra [Mar2023]

RealTime

RealTime

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2023 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us